Navigation Links
Sigma-Aldrich Corporation Will Hold Its Annual Business Review March 21, 2013
Date:2/11/2013

ST. LOUIS, Feb. 11, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), will hold its Business Review with the financial community on Thursday, March 21, 2013 at 8:30 AM Central Time.  Presenters will include: President & CEO, Rakesh Sachdev ; EVP & CFO, Jan Bertsch ; EVP & President, SAFC Commercial Markets BU, Gilles Cottier ; EVP & President, Applied Markets BU, Frank Wicks ; and EVP & President, Research Markets BU, Eric Green .

Audio Call Dial-In Information:
Domestic: (877) 266-0483
International: (707) 287-9342
Conference ID:  96450773 

Interested parties may listen via live audio broadcast and view the presentation slides over the internet available at http://investor.sigmaaldrich.com/.  Users can click the "Webcast" icon to access this file.

About Sigma-Aldrich:  Sigma-Aldrich (NASDAQ: SIAL) is a leading Life Science and High Technology company.  Its biochemical and organic chemical products and kits are used in scientific genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing.  The company has customers in life science companies, university and government institutions, hospitals and industry.  Over one million scientists and technologists use its products.  Sigma-Aldrich operates in 38 countries and has 9,000 employees providing excellent service worldwide.  The company is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its award winning website, at www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
2. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
3. Sigma-Aldrich Corporation Announces New Credit Facility
4. Sigma-Aldrich Elects Michael Marberry As Director
5. Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
6. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
7. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
8. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
9. Neogen Corporation Announces 2nd Quarter Results Conference Call
10. Luminex Corporation to Present at JP Morgan Healthcare Conference
11. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... February 24, 2017 a total of 10,672,750 common share purchase ... common share. Proceeds from the exercise of these warrants totalled ... ... are grateful for this expression of confidence by our warrant ...
(Date:2/27/2017)... YORK , February 27, 2017 ... by Stock-Callers.com for evaluation today, and they are: Anthera ... Pacific Biosciences of California Inc. (NASDAQ: PACB), and Conatus ... an article on ETF Trends, market observers are growing ... and administration could enact reforms to free cash held ...
(Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
(Date:2/27/2017)... ... February 27, 2017 , ... The Catalyst Midwest premix manufacturing facility ... offering premix services and private label organic services. , The first organic product is ... chief operating officer of Dynamite Marketing, which owns the facility. , Catalyst already has ...
Breaking Biology Technology:
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):